Issued: 9 June 2026, London UK
Dr Hal Barron - New Directorship
In accordance with UK Listing Rule 6.4.9R(2), GSK plc notes that Dr Hal Barron, a Non-Executive Director, was appointed an Independent Director and Chair of the Nominating and Corporate Governance Committee of Quantinuum Inc. on 4 June 2026.
V A Whyte
Company Secretary
9 June 2026
About GSK
GSK is a global biopharma company with a purpose to unite science, technology, and talent to get ahead of disease together. Find out more at www.gsk.com.
Registered in England & Wales:
No. 3888792
Registered Office:
79 New Oxford Street
London
WC1A 1DG